Form 8-K - Current report:
SEC Accession No. 0001193125-25-005012
Filing Date
2025-01-13
Accepted
2025-01-13 08:07:19
Documents
76
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d920572d8k.htm   iXBRL 8-K 32663
2 EX-99.1 d920572dex991.htm EX-99.1 18885
3 EX-99.2 d920572dex992.htm EX-99.2 21741
4 EX-99.3 d920572dex993.htm EX-99.3 53469
8 GRAPHIC g920572ex99_2p10g1.jpg GRAPHIC 292881
9 GRAPHIC g920572ex99_2p11g1.jpg GRAPHIC 371531
10 GRAPHIC g920572ex99_2p12g1.jpg GRAPHIC 215595
11 GRAPHIC g920572ex99_2p13g1.jpg GRAPHIC 213711
12 GRAPHIC g920572ex99_2p14g1.jpg GRAPHIC 395673
13 GRAPHIC g920572ex99_2p15g1.jpg GRAPHIC 267579
14 GRAPHIC g920572ex99_2p16g1.jpg GRAPHIC 125090
15 GRAPHIC g920572ex99_2p17g1.jpg GRAPHIC 225017
16 GRAPHIC g920572ex99_2p18g1.jpg GRAPHIC 231435
17 GRAPHIC g920572ex99_2p19g1.jpg GRAPHIC 373696
18 GRAPHIC g920572ex99_2p1g1.jpg GRAPHIC 305003
19 GRAPHIC g920572ex99_2p2g1.jpg GRAPHIC 649270
20 GRAPHIC g920572ex99_2p3g1.jpg GRAPHIC 462348
21 GRAPHIC g920572ex99_2p4g1.jpg GRAPHIC 326913
22 GRAPHIC g920572ex99_2p5g1.jpg GRAPHIC 313757
23 GRAPHIC g920572ex99_2p6g1.jpg GRAPHIC 226697
24 GRAPHIC g920572ex99_2p7g1.jpg GRAPHIC 331333
25 GRAPHIC g920572ex99_2p8g1.jpg GRAPHIC 345001
26 GRAPHIC g920572ex99_2p9g1.jpg GRAPHIC 329071
27 GRAPHIC g920572ex99_3p10g1.jpg GRAPHIC 310962
28 GRAPHIC g920572ex99_3p11g1.jpg GRAPHIC 287764
29 GRAPHIC g920572ex99_3p12g1.jpg GRAPHIC 245170
30 GRAPHIC g920572ex99_3p13g1.jpg GRAPHIC 371543
31 GRAPHIC g920572ex99_3p14g1.jpg GRAPHIC 274805
32 GRAPHIC g920572ex99_3p15g1.jpg GRAPHIC 308854
33 GRAPHIC g920572ex99_3p16g1.jpg GRAPHIC 215616
34 GRAPHIC g920572ex99_3p17g1.jpg GRAPHIC 213705
35 GRAPHIC g920572ex99_3p18g1.jpg GRAPHIC 396877
36 GRAPHIC g920572ex99_3p19g1.jpg GRAPHIC 354801
37 GRAPHIC g920572ex99_3p1g1.jpg GRAPHIC 278334
38 GRAPHIC g920572ex99_3p20g1.jpg GRAPHIC 125138
39 GRAPHIC g920572ex99_3p21g1.jpg GRAPHIC 216769
40 GRAPHIC g920572ex99_3p22g1.jpg GRAPHIC 231265
41 GRAPHIC g920572ex99_3p23g1.jpg GRAPHIC 260208
42 GRAPHIC g920572ex99_3p24g1.jpg GRAPHIC 289153
43 GRAPHIC g920572ex99_3p25g1.jpg GRAPHIC 301908
44 GRAPHIC g920572ex99_3p26g1.jpg GRAPHIC 334911
45 GRAPHIC g920572ex99_3p27g1.jpg GRAPHIC 378981
46 GRAPHIC g920572ex99_3p28g1.jpg GRAPHIC 284986
47 GRAPHIC g920572ex99_3p29g1.jpg GRAPHIC 231501
48 GRAPHIC g920572ex99_3p2g1.jpg GRAPHIC 637974
49 GRAPHIC g920572ex99_3p30g1.jpg GRAPHIC 399930
50 GRAPHIC g920572ex99_3p31g1.jpg GRAPHIC 303171
51 GRAPHIC g920572ex99_3p32g1.jpg GRAPHIC 361293
52 GRAPHIC g920572ex99_3p33g1.jpg GRAPHIC 167304
53 GRAPHIC g920572ex99_3p34g1.jpg GRAPHIC 264937
54 GRAPHIC g920572ex99_3p35g1.jpg GRAPHIC 340396
55 GRAPHIC g920572ex99_3p36g1.jpg GRAPHIC 277315
56 GRAPHIC g920572ex99_3p37g1.jpg GRAPHIC 274217
57 GRAPHIC g920572ex99_3p38g1.jpg GRAPHIC 278205
58 GRAPHIC g920572ex99_3p39g1.jpg GRAPHIC 309642
59 GRAPHIC g920572ex99_3p3g1.jpg GRAPHIC 462993
60 GRAPHIC g920572ex99_3p40g1.jpg GRAPHIC 349698
61 GRAPHIC g920572ex99_3p4g1.jpg GRAPHIC 325759
62 GRAPHIC g920572ex99_3p5g1.jpg GRAPHIC 313850
63 GRAPHIC g920572ex99_3p6g1.jpg GRAPHIC 277441
64 GRAPHIC g920572ex99_3p7g1.jpg GRAPHIC 329153
65 GRAPHIC g920572ex99_3p8g1.jpg GRAPHIC 345287
66 GRAPHIC g920572ex99_3p9g1.jpg GRAPHIC 407249
67 GRAPHIC g920572g0111021112453.jpg GRAPHIC 3003
  Complete submission text file 0001193125-25-005012.txt   25559533

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dawn-20250113.xsd EX-101.SCH 2856
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20250113_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20250113_pre.xml EX-101.PRE 11265
78 EXTRACTED XBRL INSTANCE DOCUMENT d920572d8k_htm.xml XML 3654
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 25524914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)